Legal Representation
Attorney
DERMOT J. HORGAN
USPTO Deadlines
Next Deadline
2092 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-04-29)
Due Date
April 29, 2031
Grace Period Ends
October 29, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
33 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 29, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Apr 29, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 11, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 11, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 5, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 14, 2025 | EXPT | T | EXPARTE APPEAL TERMINATED | Loading... |
| Feb 14, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 14, 2025 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Feb 4, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Feb 4, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 4, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Feb 4, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 14, 2025 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
| Jan 14, 2025 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| Jan 14, 2025 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
| Dec 16, 2024 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Dec 16, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 16, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 17, 2024 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Oct 17, 2024 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Oct 17, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Sep 3, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 3, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Sep 3, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 3, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 26, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Mar 26, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Dec 27, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 27, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 27, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 12, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 3, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 17, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for human use in diagnosis and therapy of diseases in the fields of oncology, renal disease, cardiology, lung disease, bone disease and neuroscience; Radiopharmaceutical preparations for use in diagnostic imaging, for use in therapeutic treatments, namely the destruction of diseased tissue, and for use in the treatments of non-cancerous conditions, namely the treatment of blood disorders, and for reducing the function of overactive thyroid glands; Pharmaceutical kits for making radiopharmaceutical preparations for nuclear medical use, namely kits comprising diagnostic radioisotopes and therapeutic radioisotopes, and also containing chelating chemical agents, reducing chemical agents, buffers, ligands and targeting molecules, chemical solvents, chemical stabilizers and preservatives, isotope exchange and radiolabeling reagents, radionuclide generators, sterilizing agents, and printed and downloadable instruction manuals for synthesis, all sold as a unit
Class 010
Medical generators specially adapted for medical purposes, namely for use in the production and transportation of nuclear
medicine and component parts therefor; Radioaerosol generators, namely, nebulizers for medical use for administering
radioactive medicine and imaging solutions in gaseous form for medical imaging procedures and component parts therefor;
Elution shields for medical use, namely, nuclear medicine radiation apparatus for collection of sodium-pertechnetate from
Mo99/Tc99m generators and radiation shielding
Class 042
Pharmaceutical research and development services; providing medical research and scientific research information in the field of pharmaceuticals
Classification
International Classes
005
010
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"HEALTHCARE"